[1] Kerner W, Brückel J. Definition, classification and diagnosis of diabetes mellitus[J]. Exp Clin Endocrinol Diabetes, 2014, 122(07): 384-386.
[2] Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis[J]. Indian J Endocrinol Metab, 2012, 16(Suppl1): S27.
[3] Dogra S, Kumar B, Bhansali A, et al. Epidemiology of onychomycosis in patients with diabetes mellitus in India[J]. Int J Dermatol, 2002, 41(10): 647-651.
[4] 张雅洁, 张桂梅, 徐丹, 等. 糖尿病患者趾甲真菌病的患病率及易感因素[J]. 中华皮肤科杂志, 2004, 37(4): 212-214.
[5] Saunte D M L, Holgersen J B, Hdersdal M, et al. Prevalence of toe nail onychomycosis in diabetic patients[J]. Acta Derm Venereol, 2006, 86(5): 425-428.
[6] Gulcan A, Gulcan E, Oksuz S, et al. Prevalence of toenail onychomycosis in patients with type 2 Diabetes Mellitus and evaluation of risk factors[J]. J Am Podiatr Med Assoc, 2011, 101(1): 49-54.
[7] Chang S J, Hsu S C, Tien K J, et al. Metabolic syndrome associated with toenail onychomycosis in Taiwanese with diabetes mellitus[J]. Int J Dermatol, 2008, 47(5): 467-472.
[8] Lecube A, Pachón G, Petriz J, et al. Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement[J]. PloS one, 2011, 6(8): e23366.
[9] Khan S, Raghuram G V, Pathak N, et al. Impairment of mitochondrial–nuclear cross talk in neutrophils of patients with type 2 diabetes mellitus[J]. Indian J Clin Biochem, 2014, 29(1): 38-44.
[10] 牛云彤, 沈继春, 卢涛, 等. 正常人甲真菌病与糖尿病患者甲真菌病的比较[J]. 中国真菌学杂志, 2013, 8(5): 291-293.
[11] Tan JS, Joseph WS. Common fungal infections of the feet in patients with diabetes mellitus[J]. Drugs Aging, 2004, 21(2): 101-112.
[12] Van Duyn Graham L, Elewski B E. Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US[J]. Mycoses, 2011, 54(6): e679-e685.
[13] Yin Z Q, Xu J L, Luo D. A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole[J]. J Dermatolog Treat, 2012, 23(6): 449-452.
[14] Matricciani L, Talbot K, Jones S. Safety and efficacy of tinea pedis and onychomycosis treatment in people with diabetes: a systematic review[J]. J Foot Ankle Res. 2011 Dec 4;4:26. doi: 10.1186/1757-1146-4-26.
[15] Farkas B, Paul C, Dobozy A, et al. Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin‐dependent and non‐insulin‐dependent diabetes mellitus: a multicentre trial[J]. BRIT J Dermatol, 2002, 146(2): 254-260.
[16] Vickers A E M, Sinclair J R, Zollinger M, et al. Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions[J]. Drug Metab Dispos, 1999, 27(9): 1029-1038.
[17] Cathcart S, Cantrell W, Elewski BE. Onychomycosis and diabetes[J]. J Eur Acad Dermatol Venereol, 2009, 23(10): 1119-1122.
[18] 谢志宏, 姚志远, 李邻峰, 等. 特比萘芬治疗糖尿病患者甲真菌病疗效和对血糖水平的影响[J]. 中国麻风皮肤病杂志, 2007, 23(9): 773-775.
[19] Gupta A K, Paquet M, Simpson F C. Therapies for the treatment of onychomycosis[J]. Clin Dermatol, 2013, 31(5): 544-554.
[20] Penev P K, Cardoso J C, Taneva T, et al. Onychomycosis: modern diagnostic and treatment approaches[J]. Wien Med Wochenschr, 2013, 163(1-2): 1-12.
[21] Dvorak Z. Drug–drug interactions by azole antifungals: Beyond a dogma of CYP3A4 enzyme activity inhibition[J]. Toxicol Lett, 2011, 202(2): 129-132.
[22] Penev P K, Cardoso J C, Taneva T, et al. Onychomycosis: modern diagnostic and treatment approaches[J]. Wien Med Wochenschr, 2013, 163(1-2): 1-12.
[23] Brenner M A, Harkless L B, Mendicino R W, et al. Ciclopirox 8% nail lacquer topical solution for the treatment of onychomycosis in patients with diabetes: a multicenter, open-label study[J]. J Am Podiatr Med Assoc, 2007, 97(3): 195-202.
[24] Nenoff P, Grunewald S, Paasch U. Laser therapy of onychomycosis[J]. J Dtsch Dermatol Ges, 2014, 12(1): 33-38.
[25] Hochman L G. Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd: YAG 1064-nm laser[J]. J Cosmet Laser Ther, 2011, 13(1): 2-5.
[26] Welsh O, Vera-Cabrera L, Welsh E. Onychomycosis[J]. Clin Dermatol, 2010, 28(2): 151-159.
[27] Takehara K, Oe M, Tsunemi Y, et al. Factors associated with presence and severity of toenail onychomycosis in patients with diabetes: A cross-sectional study[J]. Int J Nurs Stud, 2011, 48(9): 1101-1108. |
